We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEM
101
Tempus AI
TEM
$7.72B
| $8.41M | 0.21% |
+132,418
| New | +$7.59M |
|
102
Sprouts Farmers Market
SFM
$7.31B
| $8.4M | 0.21% |
51,029
+49,411
| +3,054% | +$8.07M |
|
103
SouthState Bank Corp
SSB
$10.3B
| $8.34M | 0.2% |
+90,623
| New | +$7.96M |
|
|
JNPR
104
DELISTED
Juniper Networks
JNPR
| $8.31M | 0.2% |
+208,206
| New | +$7.46M |
|
105
Upstart Holdings
UPST
$2.66B
| $8.3M | 0.2% |
+128,377
| New | +$6.29M |
|
106
Coupang
CPNG
$27.7B
| $8.22M | 0.2% |
+274,324
| New | +$7.03M |
|
107
Celestica
CLS
$40.3B
| $8.21M | 0.2% |
52,606
+42,215
| +406% | +$4.49M |
|
108
Yum! Brands
YUM
$41.4B
| $8.21M | 0.2% |
+55,419
| New | +$8.09M |
|
|
SCHW
109
Charles Schwab
SCHW
$184B
| $8.15M | 0.2% |
+89,367
| New | +$7.48M |
|
|
QXO
110
QXO Inc
QXO
$14.8B
| $8.11M | 0.2% |
376,483
+316,754
| +530% | +$5.2M |
|
111
Globus Medical
GMED
$10.9B
| $8.06M | 0.2% |
136,510
+120,909
| +775% | +$7.81M |
|
112
ASE Group
ASX
$74.4B
| $8.04M | 0.2% |
+778,353
| New | +$7.26M |
|
|
CNH
113
CNH Industrial
CNH
$14.2B
| $7.98M | 0.2% |
+615,818
| New | +$7.61M |
|
114
Verisk Analytics
VRSK
$27.8B
| $7.9M | 0.19% |
25,347
+23,400
| +1,202% | +$7.09M |
|
115
BioMarin Pharmaceuticals
BMRN
$12B
| $7.79M | 0.19% |
141,668
+137,443
| +3,253% | +$8.09M |
|
116
Applied Industrial Technologies
AIT
$12.9B
| $7.75M | 0.19% |
+33,344
| New | +$7.58M |
|
117
Arm
ARM
$261B
| $7.71M | 0.19% |
47,660
+40,661
| +581% | +$5.05M |
|
118
Palantir
PLTR
$296B
| $7.67M | 0.19% |
+56,283
| New | +$6.6M |
|
119
TotalEnergies
TTE
$187B
| $7.52M | 0.18% |
+122,527
| New | +$7.27M |
|
120
New Oriental
EDU
$8.08B
| $7.5M | 0.18% |
+138,974
| New | +$6.6M |
|
121
McKesson
MCK
$104B
| $7.5M | 0.18% |
10,229
+8,087
| +378% | +$5.71M |
|
122
Sylvamo
SLVM
$1.55B
| $7.46M | 0.18% |
+148,933
| New | +$8.39M |
|
123
United Microelectronic
UMC
$43.6B
| $7.42M | 0.18% |
970,407
+444,106
| +84% | +$3.3M |
|
124
Bunge Global
BG
$22.8B
| $7.42M | 0.18% |
+92,390
| New | +$7.27M |
|
125
Agree Realty
ADC
$9.74B
| $7.35M | 0.18% |
100,604
+97,199
| +2,855% | +$7.31M |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.